Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
tadekinig alfa | interleukin-18 | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoproliferative Syndrome X-Linked 2[MeSHID:C564469] |
NA | phase 3 | unknown |
click here to return to the previous page |